Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the best up and coming stocks with huge upside potential. On September 9, LifeSci Capital analyst Francois Brisebois reiterated a Buy rating on Centessa Pharmaceuticals and set a price target of $39.00. In Q2 2025, Centessa Pharmaceuticals reported that the company had $404.1 million in cash and investments, which is projected to fund its operations into mid-2027. The company’s R&D expenses increased to $42.7 million in Q2 2025, up from $32.8 million in Q2 ...

Rubrik Inc. (NYSE:RBRK) is one of the best up and coming stocks with huge upside potential. On September 11, CIBC raised the firm’s price target on Rubrik to $130 from $125, while keeping an Outperform rating on the shares. The firm’s positive thesis on shares was reaffirmed by the FQ2 2026 earnings report despite the conservative FQ3 outlook. CIBC forecasts revenue growth of 34% for FY2026 and 23% for FY2027. This sentiment followed Rubrik’s FQ2 2026 financial results, with total revenue reaching $310 mi ...

Chime Financial Inc. (NASDAQ:CHYM) is one of the best up and coming stocks with huge upside potential. On September 9, Chime announced the launch of its new Chime Card, which features cash back rewards and an updated design. The new secured credit card is the latest addition to Chime’s suite of fee-free banking services and is available to all new and existing members. Current Credit Builder cardholders can upgrade directly in the Chime app. The new Chime Card is designed to be more rewarding, especially ...

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the best up and coming stocks with huge upside potential. On August 28, BofA analyst Tim Anderson raised the firm’s price target on Apogee Therapeutics to $87 from $78, while keeping a Buy rating on the shares, citing estimate changes following Q2 2025 results. The Q2 2025 financial results showed that Apogee Therapeutics had a strong cash position of $621.2 million in cash, cash equivalents, and marketable securities at the end of the quarter. The financia ...

Janux Therapeutics Inc. (NASDAQ:JANX) is one of the best up and coming stocks with huge upside potential. On September 10, Truist initiated coverage of Janux Therapeutics with a Buy rating and $100 price target. Truist believes that the company’s masking platform has the potential to overcome the limitations of T-cell engagers in solid tumors by improving safety and efficacy through tumor-activated masking. For Q2 2025, Janux reported a net loss of $33.9 million, which is an increase from the $6.0 million ...

Michael Wiggins De Oliveira is an inflection investor. This means buying into cheap companies at the moment when their narrative is changing and the business is on a path toward becoming significantly more profitable over the next year.With a focus on tech and “the Great Energy Transition (including uranium)”, Michael runs a concentrated portfolio with approximately 15 to 20 stocks and an average holding period of 18 months. Through his 10+ years analyzing countless companies, Michael has accumulated outsta ...

On the initiative and decision of the Board of the public joint stock company Invalda INVL the extraordinary general meeting of shareholders of the public joint stock company Invalda INVL (identification code 121304349, the registered address Gynėjų str. 14 Vilnius, Lithuania) is to be held on 7 October 2025 at 9:00 a.m. in the premises located in Gynėjų str. 14, Vilnius. Shareholder registration begins at 8:30 a.m. and ends at 8:55 a.m. The total number of shares of the Company amounts to 12,299,375. Given ...

Hovis CEO Jon Jenkins is stepping down after three years in the lead role at the UK bakery business. Jenkins departure follows the August confirmation that Associated British Foods (ABF), the Kingsmill and Sunblest bakery brand owner through its Allied Bakeries unit, was buying Hovis from private-equity firm Endless. According to a brief statement from Hovis, Jenkins will relinquish the CEO job in "mid-September". Aidan Robson, a managing partner at Endless, said: “I would like to thank Jon for his supp ...

Traders fighting with near certainty say the Federal Reserve will cut interest rates by 25 basis points this week. Joining us to discuss the former New York Fed president, Bill Dudley. But welcome back, sir.Let's get straight to it. What are you expecting to see this coming Wednesday. Right along with everybody else.I expect a quarter point cut. It's baked in the cake. I'd be surprised if it did do anything else.Do you think they'll guide much beyond that. Well, there'll be guidance because they're going to ...

Chinese regulators, on a day of U.S. trade talks, said that an acquisition by Nvidia had violated antimonopoly regulations. ...